US Patent Issued to AB-BIOTICS on Sept. 15 for "Probiotic composition for the treatment of COVID-19" (Spanish Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,201, issued on Sept. 15, was assigned to AB-BIOTICS S.A. (Sant Cugat del Valles, Spain).

"Probiotic composition for the treatment of COVID-19" was invented by Jordi Espadaler Mazo (Sant Cugat del Valles, Spain), Ariana Salavert Larrosa (Sant Cugat del Valles, Spain), Sergi Audivert Brugue (Sant Cugat del Valles, Spain) and Miquel Angel Bonachera Sierra (Sant Cugat del Valles, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "A probiotic composition comprising Lactobacillus plantarum CECT 30292, Lactobacillus plantarum CECT 7484, Lactobacillus plantarum CECT 7485, and Pediococcus acidilactici CECT 7483 is provided. The probiotic composition is us...